Overview of Advil PM

Property	Description
Active Ingredients	Ibuprofen, Diphenhydramine Citrate
Form	Coated tablet or Caplet (for oral use)
Pharmacological Class	Analgesic, NSAID, First-Generation Antihistamine
General Purpose	Managing minor pain coupled with sleeplessness
Origin	Synthetic

The medication Advil PM is an Over-the-Counter (OTC) fixed-dose combination product designed for oral administration that functions as a dual-action agent for minor pain relief and sleep aid. This particular formulation, featuring the pairing of Ibuprofen and Diphenhydramine, is clinically recognized for its utility in addressing the combination of physical discomfort and associated wakefulness.

Composition and Form: Ibuprofen and Diphenhydramine

The composition relies on two distinct synthetic active ingredients: Ibuprofen and Diphenhydramine Citrate. Ibuprofen is the Non-Steroidal Anti-Inflammatory Drug (NSAID) component, which works to reduce inflammation and pain signaling. The inclusion of Diphenhydramine Citrate leverages its well-documented sedative property to act as the primary sleep aid in the formulation, differing from daytime pain relievers. This combination is consistently presented as a smooth caplet or a coated tablet for ease of oral consumption.

What is Advil PM's General Purpose?

The general purpose of this medicine is to address the specific scenario where minor pain prevents an individual from achieving or maintaining sleep. The analgesic and anti-inflammatory properties of the NSAID component reduce the physical sensation of discomfort, while the sedative effects of the antihistamine work concurrently to promote rest. This dual-action provides a crucial benefit by directly managing both elements—the discomfort and the subsequent wakefulness—in a single product.

Regulatory References

What side effects are possible with Advil PM?

Possible Side Effects and Safety Information

Advil PM's safety profile is a combination of the officially documented risks associated with Ibuprofen (an NSAID) and Diphenhydramine (a first-generation antihistamine). Regulatory documents classify adverse reactions based on the physiological systems affected and their expected frequency.

Adverse Reaction Classifications

Side effects are formally grouped by System-Organ Class (SOC), including Gastrointestinal Disorders, Nervous System Disorders, and Renal and Urinary Disorders. Common adverse reactions typically noted in regulatory labeling include drowsiness (somnolence), dizziness, dry mouth (xerostomia), and gastrointestinal upset such as dyspepsia and nausea.

Serious Adverse Reactions and Safety Constraints

The label explicitly details severe, rare risks associated with the NSAID component. These serious adverse reactions include potentially fatal Gastrointestinal bleeding, ulceration, and perforation. There is also a documented increased risk of Arterial Thrombotic Events, such as Myocardial Infarction and Stroke. The product is contraindicated for use in patients undergoing Coronary Artery Bypass Graft (CABG) surgery and should be avoided during late-stage pregnancy (20 weeks or later) due to potential fetal complications.

Population and Duration Patterns

Regulatory documents specify heightened risks for certain populations. Older adults have a documented increased risk of serious GI adverse events and are more susceptible to anticholinergic effects (e.g., urinary retention, confusion). Furthermore, the risk of serious cardiovascular and gastrointestinal events is noted to increase with longer use and higher doses of the NSAID component. The official safety documentation emphasizes that drowsiness will occur upon use.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of the Ibuprofen and Diphenhydramine combination product (Advil PM) presents risks from both active components, as documented by regulatory authorities. The official overdose profile is defined by both CNS toxicity and systemic organ toxicity.

Documented Manifestations and Severe Outcomes

Exposure to quantities exceeding recommended use may lead to Central Nervous System (CNS) effects such as agitation, confusion, severe headache, lethargy, and drowsiness. More severe, life-threatening outcomes include seizures and progression to coma. Gastrointestinal manifestations include abdominal pain, vomiting, and the critical risk of severe stomach bleeding or perforation. The profile also includes the risk of systemic toxicities such as acute renal failure, hypotension (low blood pressure), and severe heart rhythm disturbances. Elderly patients are documented to be at greater risk for serious gastrointestinal events.

Mandated Emergency Action

In case of a suspected overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is considered critical for adults and children, even if symptoms are not yet noticeable. Regulators explicitly instruct that immediate emergency services must be contacted if the affected individual is hallucinating, has a seizure, has trouble breathing, or cannot be awakened. Treatment is primarily symptomatic and supportive, as no specific antidote is officially listed.

Therapeutic Uses of Advil PM

The therapeutic scope of Advil PM is used for managing the combination of symptoms related to physical discomfort and associated wakefulness. This dual-action approach is applicable within clinical settings that involve acute or disruptive symptom patterns, and supports the patient during difficult episodes by easing distress. The medication's therapeutic scope is applicable for the relief of occasional sleeplessness when associated with minor aches and pains.

The product is generally applied in addressing symptom clusters that may become intense or disruptive, such as difficulty falling asleep or staying asleep in situations where patients experience minor pain. It is commonly used across conditions presenting with acute episodes of pain-driven wakefulness, including headache, muscle aches, backache, toothache, and minor arthritis pain.

“Advil PM provides supportive relief when these symptoms interfere with routine activities, contributing to easing the overall symptom load.”

Managing Nighttime Discomfort

This medication is commonly used in situations involving symptoms related to physical discomfort when these symptoms become more noticeable and create noticeable physiological strain. It is relevant when supportive symptom management is appropriate, and offers symptomatic relief that may help patients cope more steadily with difficult nighttime episodes.

Quick Fact: Relief for Pain-Associated Sleeplessness This product is relevant for managing episodes of occasional sleeplessness that are associated with the presence of minor aches and pains, assisting with maintaining functional stability during symptomatic phases.

Regulatory References

NIH DailyMed Label

Eligibility and Restrictions for Use

Who Can and Cannot Use Advil PM?

Regulatory documentation defines specific populations and health states that determine eligibility for using Advil PM (Ibuprofen/Diphenhydramine).

Contraindicated and Non-Eligible Populations

The product is contraindicated and must not be used by patients who have had an allergic reaction to aspirin or any other pain reliever/fever reducer, or by patients immediately before or after heart bypass surgery (CABG). Use is also prohibited if the individual is already taking any other product containing diphenhydramine.

Age-Related Rules and Restrictions

The medicine is not for use in children under 12 years of age. For patients aged 60 or older, consultation with a health professional is required due to increased risk of side effects. Additionally, the medicine must not be used for sleeplessness alone; it is indicated only when sleeplessness is associated with minor aches and pains.

Conditional Use and Special Status

Individuals with pre-existing conditions—including heart disease, high blood pressure, asthma, kidney disease, liver cirrhosis, glaucoma, or enlarged prostate—must ask a doctor before use. For pregnant or breast-feeding individuals, the product label requires consultation with a health professional. Specifically, ibuprofen must not be used at 20 weeks or later in pregnancy unless directed by a doctor.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Advil PM, a fixed-dose combination of an NSAID (Ibuprofen) and a first-generation antihistamine (Diphenhydramine), has officially documented interactions primarily related to pharmacodynamic reinforcement and altered clearance.

Prohibited Concurrent Use Restrictions

Regulatory labeling establishes that Advil PM must not be co-administered with any other products containing diphenhydramine, including those used topically. Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as Naproxen, is also restricted due to the heightened risk of serious gastrointestinal events. Ibuprofen is formally contraindicated for pain treatment immediately before or after Coronary Artery Bypass Graft ( CABG) surgery.

Pharmacodynamic Amplification

Co-administration with alcohol or other CNS depressants (sedatives, tranquilizers, other sleep aids) is documented to cause an additive effect, significantly increasing drowsiness. The Ibuprofen component increases the risk of serious GI bleeding when combined with Anticoagulants (blood thinners) and Steroid Drugs. MAO Inhibitors prolong and intensify the anticholinergic effects of diphenhydramine.

Exposure and Clearance Alterations

The Ibuprofen component can reduce the renal clearance of certain medicines, leading to increased plasma concentrations of agents such as Lithium and Methotrexate. Additionally, Ibuprofen may decrease the antiplatelet benefit of low-dose Aspirin when used for cardioprotection. The NSAID component can also impair the therapeutic effectiveness of Diuretics.

Population-Specific Notes

The risk of severe stomach bleeding from these interactions is explicitly noted as being higher in individuals age 60 or older and those with a history of stomach ulcers or bleeding problems.

Mechanism of Action

Modulating Peripheral Nociception via COX Enzymes

The Ibuprofen component exerts its effect by functioning as a non-selective, reversible inhibitor of the Cyclooxygenase (COX-1 and COX-2) enzymes. This inhibition blocks the synthesis of prostaglandins, which are key chemical mediators in nociceptive signaling. This mechanism is primarily relevant in contexts involving humoral inflammatory mediators, and its resulting physiological effect is to limit the amplification of peripheral nociceptive signals.

Suppressing Central Arousal via H₁ Antagonism

The Diphenhydramine component exerts its effect by functioning as a competitive antagonist at central Histamine H₁ receptors within the brain. By blocking these receptors, it suppresses activity in the histaminergic arousal system, a central pathway that regulates vigilance and alertness. This mechanism targets signaling patterns characteristic of neural pathways associated with wakefulness, leading to the predictable physiological adjustment of CNS depression that contributes to a state of somnolence.

Functional Complementarity of Dual Mechanisms

This combination employs two independent mechanisms—one peripheral and one central—to modulate distinct biological systems. The peripheral modulation limits the synthesis of prostanoids, while the central antagonism suppresses the CNS arousal system. This functional complementarity engages distinct pathways by simultaneously limiting peripheral nociceptive signaling and suppressing the CNS arousal system.

Dosage and Administration Information

Advil PM is administered via the oral route as a coated caplet, tablet, or capsule containing a fixed combination of ibuprofen and a diphenhydramine salt. The standard administration pattern involves taking a single dose of two units at bedtime. This fixed dose delivers a total of 400 mg of Ibuprofen and the corresponding dose of the diphenhydramine component.

The dosing frequency is strictly limited to once daily. No more than two units (the standard single dose) should be consumed within a 24-hour period. This administration must occur at bedtime and is restricted to times when the user is able to allow for a full night’s sleep.

The medication is for use in adults and children 12 years of age and older, with use in children under 12 years being explicitly prohibited. Usage is short-term, meaning it should not exceed 10 days for pain relief. When used as a sleep aid, continuous administration is limited to no more than 14 days.

To ensure appropriate administration, the single two-unit dose should not be combined with any other product containing diphenhydramine. Furthermore, the medication may be administered with food or milk if the user experiences stomach upset. These parameters define the fixed-schedule protocol for the product.

Recent Clinical Evidence

Advil PM: Recent Clinical Evidence

Evidence for Occasional Sleeplessness Associated with Minor Pain

The foundation of research for this fixed-dose combination consists of single-dose, double-blind Randomized Controlled Trials (RCTs). These studies evaluated the combination when compared to a placebo and to the pain-relieving component (ibuprofen) taken alone. Trials were relevant in evidence describing how symptoms are measured in studies examining short-term or episodic symptom patterns, helping to understand short-term changes in both perceived physical discomfort and rest quality.

Study Outcomes and Duration

Studies monitored outcomes related to functional imbalance, including objective measurements of Total Sleep Time (TST), the amount of time subjects were awake after first falling asleep (Wake After Sleep Onset), and the time required to fall asleep (Sleep Latency). Researchers also tracked the time subjects went without requesting additional pain relief. The evidence base for this medicine was developed using research exploring short-term changes, primarily through single-dose studies.

Evidence in Specific Populations and Gaps

The study populations primarily consisted of adults and adolescents 12 years of age and older. The research shows that data for certain groups remain insufficient, specifically highlighting limited information available for the geriatric population (older adults).

One of the primary research limitation frames is the predominance of single-dose study designs, meaning the effects of repeated short-term administration are not fully established by the core evidence. Furthermore, there is limited objective research exploring detailed sleep architecture and the potential for residual next-day effects or changes in functional status. Comparative evidence for certain subgroups may also be lacking.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Advil PM (FAQ)

Q: Can Advil PM be taken if I only have trouble falling asleep, but no pain?

A: According to the official product information, this medication is indicated only for occasional sleeplessness that is associated with minor aches and pains. Regulatory documents state the product should not be used for sleeplessness alone. Its purpose is to address the specific scenario where physical discomfort is preventing rest.

Q: Is it normal to feel groggy the morning after taking Advil PM?

A: The sleep aid component in this medication can lead to feelings of drowsiness and dizziness. Official documents note that daytime drowsiness or a 'hangover' feeling are among the common adverse effects reported by users.

Q: Can Advil PM affect my ability to drive the next day?

A: Yes, official instructions state that drowsiness will occur upon using the medication. For safety, regulatory guidance indicates that operating complex machinery or driving should be avoided after taking it.

Q: What happens if I take Advil PM and only sleep for a few hours?

A: The official label recommends avoiding use unless you can allow for a full night's sleep. This guidance is in place because the sedative effects are intended to last throughout that duration, due to the possibility of residual sedation upon waking.

Q: Why does the label warn against taking it for more than a few nights?

A: Official information indicates that continuous use should be limited, and suggests discontinuing use and seeking advice if sleeplessness persists for more than two weeks. This is because persistent insomnia can sometimes signal a more serious underlying medical condition that requires a different approach.

Q: Why is it advised to avoid Advil PM if I have heart failure?

A: The ibuprofen component belongs to a class of medicines called NSAIDs, which carry an official warning regarding cardiovascular risk. Regulatory documents specifically indicate that NSAIDs, other than aspirin, may increase the risk of heart attack and heart failure. This is a primary reason why official instructions require a consultation with a healthcare professional before use for individuals with heart issues.

Q: Does Advil PM help with pain from arthritis or just general aches?

A: The medication is officially indicated for the management of occasional sleeplessness associated with minor aches and pains. This can include common pains such as headaches, menstrual cramps, or toothaches. The product is generally designed for the short-term relief of minor discomfort.

Q: Can Advil PM make existing glaucoma worse?

A: The official product labeling requires that individuals who have glaucoma consult with a doctor or health professional before taking this medicine. This is a general safety constraint noted in regulatory documents for individuals with this specific eye condition.

Q: Is there any research on the effectiveness of the combination of ibuprofen and diphenhydramine?

A: Studies and official information indicate that the combination of ingredients has been evaluated for its indicated use. Clinical research describes the utility of the product for the short-term relief of occasional sleeplessness that is associated with minor aches and pains.

Q: What types of pain is Advil PM specifically formulated to address?

A: According to official product labeling, this medication is indicated for minor aches and pains that interfere with sleep. Specific examples of the pain types listed include headache, back pain, toothache, and menstrual cramps.

Q: Can Advil PM make existing asthma worse?

A: Regulatory guidance specifies that individuals with asthma or a chronic breathing problem must consult a doctor before use. Furthermore, the label identifies use as contraindicated if a person has ever had an asthma attack after taking aspirin or any other Non-Steroidal Anti-Inflammatory Drug (NSAID) like ibuprofen.

Q: Can Advil PM be used for muscle cramps associated with sleep?

A: The product's official indication covers occasional sleeplessness associated with minor aches and pains. While muscle cramps are not explicitly listed in the indication, official documents note the product's use for minor muscle pain.

Q: What does the drug's monograph say about use by teenagers or children?

A: Regulatory documentation strictly states that the product is not approved for use by anyone younger than 12 years of age. Official directions specify the appropriate dose only for adults and for children 12 years and over.

Q: What are the risks of taking Advil PM if I have kidney problems?

A: The official label requires individuals with kidney disease to consult a healthcare professional prior to use. Additionally, regulatory documents describe the need to discontinue use and consult a healthcare professional if signs of kidney problems are observed, such as reduced urination or swelling in the feet or ankles.

Q: How long does the sleepiness effect from Advil PM typically last?

A: Official product guidance emphasizes that the medication should only be taken when there is time for a full night’s sleep. This instruction is an indication that the sedative effects are intended to persist for the duration of a typical sleep cycle.

Q: What does 'antihistamine' mean in the context of Advil PM's sleep aid?

A: The sleep-aid component, diphenhydramine, is classified as an antihistamine. In the context of this medication, it acts by blocking certain histamine receptors in the brain, a mechanism that suppresses the central arousal system and results in sleepiness.

Q: What evidence exists to support Advil PM’s dual action of pain relief and sleep aid?

A: The dual action of the medication is supported by clinical studies that have evaluated the combination of ibuprofen and diphenhydramine. Clinical evidence describes the utility of the product for the short-term relief of occasional sleeplessness associated with minor aches and pains, which is the official indication.

Q: What are the common signs of an allergic reaction to Advil PM's ingredients?

A: Official warnings on the product label describe signs of a severe allergic reaction. These may include the development of hives, swelling of the face, or breathing difficulty such as wheezing. More severe signs listed are shock, extensive rash, or blistering.

How should Advil PM be stored and disposed of?

How to Store and Dispose of Advil PM

Advil PM must be stored in compliance with regulatory labeling to maintain the stability of its Ibuprofen and Diphenhydramine Citrate components.

Storage Requirements

The product must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F). The medication should be kept in its original container and the cap must remain tightly closed to protect it from moisture. A crucial requirement is to store the product out of the reach of children.

Disposal Instructions

To discard unused or expired Advil PM, individuals are directed to follow local regulations. The official method involves utilizing a drug take-back program. If this option is unavailable, the product should be prepared for household trash by mixing it with an undesirable substance, then sealing it in a plastic bag before disposal.

Advil PM